ABSTRACT: Voltage-gated potassium channels formed by KCNQ2 and KCNQ3 are essential for normal neuronal excitability. KCNQ2/3 channel activity is augmented in vivo by phosphatidylinositol 4,5-bisphosphate (PIP 2 ), which is generated from myo-inositol, an osmolyte transported into cells by sodium-dependent myo-inositol transporters (SMITs). Here, we discovered that KCNQ2/3 channels isoform-specifically colocalize with SMIT1 and SMIT2 at sciatic nerve nodes of Ranvier and in axon initial segments, and form channel-transporter complexes in vitro and in vivo. KCNQ2/3 coexpression protected SMIT1 activity from the otherwise inhibitory effects of cellular depolarization imposed by elevating extracellular [K + ], and KCNQ2 was required for potentiation of SMIT activity by myo-inositol preincubation. Cytoskeletal disruption, which speeds PIP 2 dispersion, attenuated potentiation of KCNQ2/3 currents by SMIT1-mediated myo-inositol uptake, suggesting close channel-transporter juxtaposition ensures KCNQ2/3 exposure to locally high myo-inositol-derived PIP 2 concentrations. Thus, KCNQ2/3-SMIT1/2 coassembly permits cross talk via physical interaction, and may also be required for optimal, reciprocal indirect regulation via membrane potential and PIP 2 , especially within the specialized architecture of axons.-Neverisky, D. L., Abbott, G. W. KCNQ-SMIT complex formation facilitates ion channel-solute transporter cross talk. FASEB J. 31, 2828-2838 (2017 
Voltage-gated potassium (K v ) channel a subunits of the KCNQ (K v 7) gene family serve a variety of functions in different cell types in higher animals. Heteromers formed by KCNQ2 and KCNQ3 (K v 7.2 and K v 7.3) generate the M current in mammalian neurons, a noninactivating, muscarinic-inhibited K v current that regulates electrical activity in the brain by raising the threshold for neuronal activation (1) . In human heart, complexes formed by KCNQ1 (K v 7.1) and the single-transmembrane spanning b subunit KCNE1 generate the slow-activating, noninactivating I Ks current that helps to repolarize the myocardium to end each heartbeat, especially in conditions of b-adrenergic stimulation (2, 3) . In gastric parietal cells, KCNQ1-KCNE2 complexes generate a constitutively active current potentiated by low extracellular pH, which facilitates gastric acid secretion by recycling K + to the luminal side of the gastric H + /K + -ATPase (4, 5). KCNQ1-KCNE2 channels are also required for optimal thyroid hormone secretion, and they facilitate function of the sodium-coupled iodide symporter in thyroid cells by mechanisms not yet completely understood (6, 7) .
We recently found that KCNQ1-KCNE2 channels can coassemble with SMIT1 to form a K + channel-solute transporter (chansporter) complex. This newly recognized class of signaling complexes facilitates reciprocal regulation of both subunit types, and in the case of KCNQ1-KCNE2-SMIT1, its disruption in mice by Kcne2 deletion leads to dysregulation of cerebrospinal fluid myo-inositol and increased seizure susceptibility (8) . Myo-inositol is a cyclic polyol that plays an important role as an osmolyte in mammalian systems; cells can take up myo-inositol via myoinositol transporters such as SMIT1 to protect themselves from hypertonic extracellular conditions (9) . Myo-inositol also forms the head group of phosphoinositides including PIP 2 , which is well established to be a crucial regulator of the function of membrane proteins including ion channels (10) . Recently, PIP 2 derived from myo-inositol transported into the cell by SMIT1 was shown to be sufficient to regulate neuronal excitability, suppressing firing by negatively shifting the voltage dependence of KCNQ2/3 channel opening (11) . This demonstrated a previously largely overlooked ABBREVIATIONS: CHO, Chinese hamster ovary; GFP, green fluorescent protein; K v , voltage-gated potassium; PIP 2 , phosphatidylinositol 4,5-bisphosphate; SMIT, sodium-dependent myo-inositol transporter; TBS, Tris-buffered saline; TEVC, 2-electrode voltage clamp link between extracellular hypertonicity and electrical excitability. However, the possibility of direct interaction between KCNQ2/3 and SMIT1 was not investigated.
MATERIALS AND METHODS

Immunofluorescence
For Chinese hamster ovary (CHO) cell immunofluorescence, SMIT1-FLAG was detected using anti-DDK (OriGene Technologies, Rockville, MD, USA); KCNQ2-green fluorescent protein (GFP) was observed directly without additional antibody. Images were captured with a Leica SP8 confocal microscope (Leica, Wetzlar, Germany). A z stack of the entire cell depth was captured, allowing isolation of the bottom layer to best visualize the boundaries of the plasma membrane. Analyses were performed with ImageJ [Image Processing and Analysis in Java; National Institutes of Health (NIH), Bethesda, MD, USA; http://imagej.nih.gov/) and Volocity (PerkinElmer, Waltham, MA, USA] software.
For mouse brain analysis, Slc5a3 +/+ and Slc5a3 2/2 mice were bred from Slc5a3 +/2 breeding pairs, the kind gift of G. Berry (Harvard Medical School, Boston, MA, USA). All mice were housed in pathogen-free facilities, and the study was approved by the Animal Care and Use Committee at University of California, Irvine. Studies were performed during the light cycle and were carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals (NIH). Mice were humanely killed by CO 2 asphyxiation; tissues were collected and snap frozen in chilled isopentane for use in later experiments. For immunofluorescence studies of mouse brain, frozen sections were prepared using a cryostat with Optimal Cutting Temperature (OCT) compound embedding (Sakura Finetek, Torrance, CA, USA). After mounting on slides, frozen sections were either fixed and permeabilized with ice-cold acetone or left unfixed and permeabilized with 0.1% Triton X-100 in Trisbuffered saline (TBS), then blocked for 1 to 2 h with 10% donkey serum, and 1% bovine serum albumin in TBS with 0.025% Triton X-100. Following this, sections were incubated overnight with primary antibodies diluted 1/100 in TBS with 0.025% Triton X-100: rabbit anti-SMIT1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and goat anti-KCNQ2 (Santa Cruz Biotechnology). After washing 3 times for 5 min, sections were incubated for 1 to 2 h in secondary antibodies (1/200 in TBS) raised in donkey (Thermo Fisher Scientific, Waltham, MA, USA) before a final wash, mounting with DAPI-containing antifade solution and visualization on an Olympus BX51 microscope with Cell-Sens software (Olympus, Tokyo, Japan). For mouse and rat sciatic nerve sections, frozen sections were purchased from Zyagen (San Diego, CA, USA), permeabilized (not fixed) in TBS with 0.1% Triton X-100, blocked for 1 to 2 h with 10% donkey serum, and 1% bovine serum albumin in TBS with 0.1% Triton X-100, then incubated overnight with primary antibodies diluted 1/100 in TBS with 0.1% Triton X-100: rabbit anti-SMIT1 (Santa Cruz Biotechnology), rabbit anti-SMIT2 (MBL International, Woburn, MA, USA), rabbit anti-ankyrin G (Santa Cruz Biotechnology), and goat anti-KCNQ2 or KCNQ3 (Santa Cruz Biotechnology). Other steps were as for the mouse brain sections, as previously described.
Xenopus laevis oocyte preparation and myo-[ 2-3 H(N)]inositol uptake assays cRNAs were generated from linearized plasmids containing target cDNA. In vitro cRNA synthesis was performed using T3, T7, or SP6 mMessage mMachine kits (Ambion, Austin, TX, USA 
Two-electrode voltage clamp
Two-electrode voltage clamp (TEVC) recording was performed at room temperature with an OC-725C amplifier (Warner Instruments, Hamden, CT, USA) and pClamp8 software (Molecular Devices, Sunnyvale, CA, USA) 4 to 5 d after cRNA injection as described above. Oocytes were placed in a small-volume oocyte bath (Warner Instruments) and viewed with a dissection microscope. Bath solution was (mM): 96 NaCl, 4 KCl, 1 MgCl 2 , 1 CaCl 2, and 10 HEPES (pH 7.6). Preincubations with cytochalasin D or wortmannin (Sigma-Aldrich) were performed in SBB storage solution (Ecocyte). Pipettes were of 1 to 2 MV resistance when filled with 3 M KCl. Currents were recorded in response to pulses between 280 and 40 or 60 mV at 10-mV intervals, or a single pulse to +40 mV, from a holding potential of 280 mV, to yield current-voltage relationships and current magnitude, and for quantifying the activation rate. TEVC data analysis was performed with Clampfit (Molecular Devices) and Origin 6.1 (OriginLab, Northampton, MA, USA) software; values are stated as means 6 SEM. Normalized tail currents were plotted vs. prepulse voltage and fitted with a single Boltzmann function according to the following equation:
where g is the normalized tail conductance, A 1 is the initial value at 2', A 2 is the final value at +', V ½ is the half-maximal voltage of activation, and V s the slope factor. KCNQ2/3 activation at 240 mV was fit with a single exponential function. Where informative, currents were compared with one another using 1-way ANOVA to assess statistical significance (P , 0.05). If multiple comparisons were performed, a post hoc Tukey's HSD test was performed after ANOVA.
cDNA per 10-cm plate and allowed 36 to 48 h expression at 37°C before lysis. Lysis buffer was composed of 1% IGEPAL, 0.1% SDS, 50 mM Tris (pH 8.0), 150 mM NaCl, and a protease inhibitor cocktail tablet (Thermo Fisher Scientific). Total protein was quantified by the bicinchoninic acid method (Thermo Fisher Scientific). Proteins were resolved by SDS-PAGE and transferred onto PVDF membranes for immunoblotting with the following antibodies, as noted: KCNQ2 (Santa Cruz Biotechnology), DDK/ FLAG (OriGene Technologies; Sigma-Aldrich), and SMIT1 (Santa Cruz Biotechnology). For secondary detection, horseradish peroxidase-conjugated antibodies (Bio-Rad, Hercules, CA, USA) were used in conjugation with Luminata Forte horseradish peroxidase substrate (EMD Millipore, Billerica, MA, USA). Imaging was performed by G:Box hardware and software (Syngene, Frederick, MD, USA). For brain tissue biochemistry, tissue was minced and homogenized in a buffer containing 150 mM NaCl, 50 mM Tris-HCl (pH 7.4), 1% IGEPAL, 1% CHAPS, 1% Triton X-100, 1% SDS, and 1 mini protease inhibitor cocktail tablet per 10 ml (Thermo Fisher Scientific) and mixed at 4°C for 2 h. Samples were cleared of insoluble fractions by centrifugation before performing coimmunoprecipitation. For coimmunoprecipitation, all samples were first precleared of nonspecific interaction by incubating the total lysate with protein A/G Plus-coated agarose beads (Santa Cruz Biotechnology) for 1 h. Beads were then pelleted and discarded. Total protein was quantified by bicinchoninic acid, as above. Immunoprecipitating antibodies were then added at a concentration of 1:100 for overnight pulldown at 4°C. The following day, antibody-antigen complexes were pulled down with fresh protein A/G Plus agarose beads before Western blot analysis.
Surface expression experiments were performed by culturing and transfecting CHO cells as above, followed by PBS wash and 30 min incubation at 4°C in a PBS solution containing 1 mg/ml EZ-Link Sulfo-NHS-SS-Biotin (Thermo Fisher Scientific). The reaction was then quenched by a subsequent wash with 50 mM Tris (pH 8.0) and PBS. Cells were then lysed, total protein quantified, and Western blotted as previously described.
CHO cell myo-[
2-3 H(N)]inositol uptake assay CHO cells were cultured in 12-well dishes and transfected with 2 mg cDNA per well, otherwise as described above. After 36 to 48 h of expression, cells were rinsed with PBS, then incubated in PBS containing 2 mCi/ml myo-[
H(N)]inositol (American Radiolabeled Chemicals) for 30 min at room temperature. Wells were then washed with PBS 4 times, and then lysed in a 0.2% SDS in PBS solution for 15 min at room temperature. Lysate from each well was then collected and transferred to individual scintillation vials for scintillation counting.
Data presentation and statistics
Data were compared by 1-way ANOVA with multiple comparisons and Bonferroni's correction or a post hoc Tukey's HSD test (GraphPad Prism; GraphPad Software, La Jolla, CA, USA and Microsoft Excel; Microsoft, Redmond, WA, USA).
RESULTS
KCNQ2/3 and SMIT1/2 isoform-specifically colocalize in rodent nervous system KCNQ2 was previously found to localize predominantly to the nodes of Ranvier region in rat sciatic nerve, whereas KCNQ3 was more often found in the paranodal region (12, 13) . Here we discovered that SMIT1 colocalized tightly with KCNQ2 in some rat sciatic nerve nodes of Ranvier. In other nodes, SMIT1 signal was absent from the KCNQ2-containing node but colocalized with paranodal KCNQ2 puncta; or KCNQ2-SMIT1 colocalization was observed in both areas (Fig. 1A) . In addition, some rat sciatic nerve nodes/paranodes exhibited KCNQ2 signal with little to no SMIT1-colocalization (Fig. 1B) . Consistent with previous reports (12) , nodal KCNQ2 consistently colocalized with ankyrin G (Fig. 1B) . In mouse sciatic nerve, SMIT1 signal was observed predominantly in the paranodes, exhibiting some localization overlap with nodal KCNQ2, which again colocalized strongly with ankyrin G (Fig. 1C) . Similar to previous findings (13), we also detected KCNQ3 predominantly in the paranodes of rat sciatic nerve, where it colocalized or was clustered close to SMIT1 (Fig. 1D) . SMIT2, encoded by SLC5A11, is a sodium-coupled myo-inositol transporter closely related to SMIT1 (14) . Strikingly, SMIT2 colocalized strongly with nodal KCNQ2 in rat sciatic nerve (Fig. 1E, F) . SMIT1 colocalization was detected in 26% of KCNQ2-positive rat sciatic nerve nodes of Ranvier, compared to 70% of nodes showing KCNQ2-SMIT2 colocalization (and 98% showing KCNQ2-ankyrin G colocalization). KCNQ3 exhibited colocalization with SMIT1 in 53% of KCNQ3-positive paranodes (Fig. 1G, H) .
We were also able to coimmunoprecipitate KCNQ2 from mouse whole-brain lysate using anti-SMIT1 antibody, whereas anti-GFP antibody (as a negative control) did not coimmunoprecipitate KCNQ2 ( Fig. 2A) . Immunofluorescence microscopy of mouse hippocampal sections revealed colocalization of signal for KCNQ2 and SMIT1, most notably in the region of axons close to the neuron soma (axon initial segment) (Fig. 2B, D) , a known location for KCNQ2/3 channels. Slc5a3 2/2 mouse brain tissue sections were used as a negative control for SMIT1 (SLC5A3) staining and showed negligible nonspecific signal (Fig. 2C) . KCNQ2 was also found to colocalize with SMIT2 in the axon close to the neuron soma (Fig. 2E) , and also with ankyrin G, a marker of the axon initial segment important for KCNQ2 localization to this region (15) (Fig. 2F ).
KCNQ2/3 diminishes SMIT1 myo-inositol uptake activity in X. laevis oocytes Having found that KCNQ2/3 and SMIT1/2 colocalize and/or coassemble in rodent nerves, we next examined the functional consequences of this. Coexpression of SMIT1 with KCNQ2/3 channels in tsA201 cells was recently found to negative-shift KCNQ2/3 voltagedependent activation after several hours' preincubation with myo-inositol (which is transported into the cell by SMIT1 and becomes a substrate for PIP 2 ) (11). Here we first recapitulated this finding for SMIT1 by using the X. laevis expression system, and we also extended it to SMIT2, which showed similar effects (Fig. 3A, B) . Accordingly, after myo-inositol preincubation, the activation V ½ of KCNQ2/3 (225.5 6 1.4 mV) was shifted by SMIT1 which was previously found to negatively shift the activation V ½ of KCNQ2/3 without altering the slope (16, 17) .
We next examined the reciprocal: that is, what effects do KCNQ2 and KCNQ3 have on SMIT1 activity, quantified by measuring tritiated myo-inositol uptake into oocytes? Surprisingly, KCNQ2 inhibited SMIT1 activity (by 70%, n = 37-149, P , 0.0001) (Fig. 3C) . Similar effects were observed for KCNQ2/3 heteromers and for KCNQ3 [which conducts far smaller currents than either KCNQ2 or KCNQ2/3 heteromers (1)], and for a nonconducting KCNQ2 selectivity filter mutant (G279S). In contrast, K v 1.1 (KCNA1), a K v channel from a different subfamily, had no effect on SMIT1 activity (Fig. 3C) . These findings suggested that KCNQ2/3 protein was important for the inhibitory effect on SMIT1 activity, but that this inhibitory effect did not require K + flux per se. Wortmannin, an inhibitor of PI3K and PI4K activity that inhibits KCNQ2/3 activity by impairing synthesis of PIP 2 , strongly inhibited KCNQ2/ 3 current, as expected. Strikingly, wortmannin also inhibited SMIT1 activity when KCNQ2/3 was coexpressed (by 40%, n = 29-31; P = 0.1) but had lesser effects in the absence of KCNQ2/3 (19% inhibition, n = 9-12; P = 0.3) (Fig. 3D) . Although the effect of wortmannin did not achieve statistical significance because of interoocyte variability, the data suggested it inhibited SMIT1 activity by impairing KCNQ2/3 activity.
Similarly, activity of SMIT2 (which colocalized with KCNQ2 in rat sciatic nerve nodes, Fig. 1E , F; and in mouse brain axon initial segment, Fig. 2E ) was inhibited by KCNQ2/3, but not by related channel KCNQ4 (Supplemental Fig. 1A) . As with SMIT1, the SMIT2 inhibition was largely resilient to KCNQ2 loss-of-function mutations in the selectivity filter and voltage sensor (Supplemental Fig. 1B) . SMIT2 exhibited reciprocal regulation, as it rescued activity of the essentially nonfunctional (18) KCNQ2-R210H mutant (n = 16-22, P , 0.0001) and augmented activity of KCNQ2-R214Q (n = 14-18, P , 0.01) (Supplemental Fig. 1C, D) .
KCNQ2 diminishes SMIT1 activity and surface expression in CHO cells via physical interaction
Because the primary inhibitory effect of KCNQ2/3 on SMIT1/2 appeared to require KCNQ2 or KCNQ3 protein but not K + flux, we hypothesized that these effects might be the result of altered SMIT1 surface expression. First, to determine whether the KCNQ2 inhibition of SMIT transport activity was Xenopus oocyte-specific vs. more general, we tested SMIT1-KCNQ2 function in CHO cells and confirmed that, as in oocytes, KCNQ2 inhibited SMIT1 activity by ;70% (n = 20 plates per subunit combination, P , 0.0001). KCNQ2 alone was used as a negative control for KCNQ2-mediated myo-inositol uptake activity in the absence of exogenous SMIT1 (Fig. 4A) . As oocytes and CHO cells exhibited similar levels of SMIT1 inhibition by KCNQ2, we tested the surface expression hypothesis using CHO cells-a more suitable system than oocytes for studying protein trafficking and cell biology-for surface biotinylation assays followed by streptavidin pulldowns and Western blot analyses. While whole-cell SMIT1 protein expression was moderately increased by KCNQ2 coexpression (by 30%, P = 0.1), KCNQ2 inhibited SMIT1 surface expression by 71% (P = 0.01) (Fig. 4B, C) . Thus, the 70% inhibition of SMIT1 activity by KCNQ2 in CHO cells, and likely in oocytes as well, can be explained by inhibition of SMIT1 surface expression by KCNQ2. This would be consistent with physical complex formation between SMIT1 and KCNQ2 in CHO cells, as we observed in rodent nervous system (Fig. 2) . Accordingly, we found that KCNQ2 physically interacts (Fig. 4D) and colocalizes (Fig. 4E) with FLAG-tagged SMIT1 in CHO cells.
KCNQ2/3-SMIT1/2 complex formation reciprocally optimizes their functionality
The final series of experiments was designed to address why complex formation might be important for KCNQ2/ 3 and SMIT1 or SMIT2. As previously demonstrated (11), here we found that coexpression of SMIT1 speeds KCNQ2/3 activation after 3 h myo-inositol incubation; we further demonstrate here that SMIT2 has similar effects and that the speeding is myo-inositol dependent in both cases (Fig. 5A-C) . It was previously shown that this effect occurs via generation of, from the transported myo-inositol, PIP 2 , which modulates KCNQ2/3 activation (11) . Earlier studies of G-protein-coupled receptors demonstrated that membrane PIP 2 diffuses relatively slowly (diffusion coefficient, D, of 0.0004 mm 2 /s) near the membrane because of binding to the actin cytoskeleton, and that disruption of the actin cytoskeleton using cytochalasin D led to rapid diffusion over the entire plasma membrane, but in contrast did not alter the rate of incorporation of PIP 2 into the plasma membrane. This speeding was shown to permit PIP 2 to diffuse rapidly away from the site of production, which would favor long-distance signaling but disfavor highly localized signaling (the local PIP 2 concentration dropped rapidly) (19) .
We therefore hypothesized that one reason for KCNQ2/3-SMIT complex formation could be to ensure the 2 protein classes were sufficiently proximal to facilitate rapid communication via high local concentration of the relatively slowly diffusing PIP 2 . Our results supported this hypothesis. Oocytes expressing KCNQ2/3 in the presence or absence of SMIT1 were preincubated with 500 mM myoinositol alone, or with wortmannin and/or cytochalasin D. Cytochalasin D strongly inhibited K v channel activity (measured by peak current at 240 mV) of KCNQ2/3-SMIT1 complexes (by 60%, n = 8-11, P , 0.01) but had no effect on KCNQ2/3 channel activity (n = 11, P = 0.44) (Fig.  5D, E) . Wortmannin inhibited KCNQ2/3 channel activity more potently in the presence of SMIT1, as might be expected if there were a robust augmenting effect on H(N)]inositol uptake by CHO cells transfected with cDNA encoding KCNQ2 (Q2), and/or SMIT1 (S1) as indicated. All bars were normalized to same-group mean SMIT1 activity alone. n for each group indicated in white text, representing number of transfected dishes over repeated experiments. Statistical comparisons made to SMIT1 baseline. ****P , 0.0001. B) Western blots of surface biotinylation studies of CHO cells transfected with KCNQ2 and/or SMIT1-FLAG as indicated; blots representative of n = 4 transfections, immunoblotted for FLAG. Arrow indicates SMIT1-FLAG band. C ) Quantification of band densities from Western blots as in B; n = 4). **P = 0.01. D) Western blots after reciprocal coimmunoprecipitations (using antibodies indicated) from CHO cells transfected with KCNQ2 and/or SMIT1-FLAG as indicated. Proteins were immunoblotted (IB) as labeled beneath each blot. Arrows indicate characteristic SMIT1 or KCNQ2 multiband patterns as indicated. E ) Representative CHO cell transfected with KCNQ2-GFP and SMIT1-FLAG. Cells were stained for FLAG in red channel; KCNQ2-GFP was visualized using native fluorescence (green). DAPI nuclear staining shown in blue. Imaging performed using confocal microscopy and representative of n = 3 transfections. Figure 5 . KCNQ2/3-SMIT coregulation is myo-inositol, depolarization, and cytoskeleton dependent. A) Representative traces (normalized to peak current) from TEVC recordings of X. laevis oocytes injected with cRNA encoding KCNQ2 (Q2) and KCNQ3 (Q3), alone or coinjected with cRNA encoding SMIT1 (S1) or SMIT2 (S2), n = 6-7, after 3 h incubation in 500 mM myo-inositol. Upper left inset: voltage protocol. B) Mean t of activation (t act ) at 240 mV fitted with single exponential function, for oocytes as in A, after 3 h incubation in 500 mM myo-inositol (n = 6-7). *P , 0.05; error bars = SEM. C ) Mean change in t act at 240 mV induced by myo-inositol (500 mM for 3 h), recorded from oocytes as in A, fitted with single exponential function (n = 9-13). *P , 0.05 vs. Q2/Q3 alone; error bars= SEM. D) Representative traces from TEVC recordings of X. laevis oocytes injected with cRNA encoding KCNQ2 (Q2), KCNQ3 (Q3), and SMIT1 (S1), n = 8-11, after 3 h incubation in 500 mM myo-inositol, in absence or presence of cytochalasin D (10 mM, 2 h). E ) Mean current (I) after preincubation with cytochalasin D and/or wortmannin as indicated, normalized to current without preincubation, for oocytes as in D, pretreated with myo-inositol (500 mM myo-inositol, 3 h; n = 8-11). *P , 0.05, **P , 0.01, ***P , 0.001 (all vs. myo-inositol alone; error bars = SEM). F ) Mean drug-induced percentage change in t act for oocytes as in D, after preincubation with cytochalasin D and/or wortmannin as indicated; all oocytes pretreated with myo-inositol (500 mM myo-inositol, 3 h; n = 8-11). *P , 0.05, **P , 0.01, ***P , 0.001 (all vs. myo-inositol alone); error bars = SEM. G) Effects of bath K + concentration (including 30 min preincubation) on mean myo-[ 2-3 H(N)] inositol uptake by CHO cells transfected with cDNA encoding SMIT1 (S1) with or without KCNQ2 (Q2) (n = 13-34 dishes). **P , 0.01; error bars = SEM. H ) Effect of cold myo-inositol preincubation (500 mM, 3 h) on subsequent myo-[ 2-3 H(N)] inositol uptake by CHO cells transfected with cDNA encoding SMIT1 (S1) and KCNQ2 (Q2), normalized to uptake for S1 alone (n = 8-25 dishes). **P , 0.01; error bars = SEM. I ) Effect of preincubation with elevated Na + (237 mM, 24 h) on subsequent myo-[ 2-3 H(N)]inositol uptake by CHO cells transfected with cDNA encoding SMIT1 (S1) and KCNQ2 (Q2), normalized to uptake for S1 alone. n = 4-16 dishes; error bars = SEM.
KCNQ2/3 activity of PIP 2 generated from myo-inositol transported through SMIT1. In contrast, inhibition of KCNQ2/3 activity by the combination of wortmannin and cytochalasin D was similar regardless of SMIT1 coexpression, as would be expected if the SMIT1-dependent effects of either drug relied on a locally high PIP 2 concentration (Fig. 5E) . We observed similar results using KCNQ2/3 activation rate at 240 mV, rather than peak current, as a metric for PIP 2 effects on KCNQ2/3 gating (Fig. 5F) .
Finally, we addressed the potential advantages for SMIT1 of coassembly with KCNQ2/3. SMIT1 is a sodiumcoupled transporter, i.e., it transports myo-inositol up a concentration gradient into the cell by exploiting the downhill electrochemical gradient for Na + . Our previous data for myo-inositol uptake were obtained in physiological low (2-4 mM) extracellular K + solutions, where the CHO cells or oocytes were at a resting potential somewhere between 240 and 280 mV, depending on the amounts and subunit combinations of the coexpressed KCNQ channels. Next, we therefore induced membrane depolarization by adding 50 mM K + to the normally 2.7 mM K + extracellular solution (PBS) and quantifying the effects on myo-[ 2-3 H(N)]inositol uptake by SMIT1 of 50 mM-elevated K + , which, using the Nernst equation, is calculated to depolarize the membrane to approximately 220 mV, ;80% of KCNQ2 V max (20) . In cells expressing SMIT1 only, elevated K + reduced myo-[ 2-3 H(N)]inositol uptake by one third (P = 0.01, n = 13-34 dishes per condition). In contrast, KCNQ2 preserved SMIT1 activity in elevated extracellular K + , which exhibited no difference from uptake measured with low extracellular K + (P = 0.68, n = 23-26 plates per condition) (Fig. 5G) .
Because KCNQ2 activity is augmented by PIP 2 derived from myo-inositol, we next tested the hypothesis that cold myo-inositol preincubation (3 h) would augment subsequent myo-[ [2] [3] H(N)]inositol uptake by SMIT1-KCNQ2 because of enhanced KCNQ2 activity. Accordingly, cold myo-inositol preincubation (500 mM, 3 h) increased subsequent myo-[ [2] [3] H(N)]inositol uptake by SMIT1-KCNQ2/3, normalized to uptake by SMIT1, by 70% (P = 0.003, n = 8-25 plates per condition) (Fig. 5H) . As a control for elevation of extracellular osmolarity, there was no KCNQ2-dependent effect on myo-inositol uptake when we elevated extracellular Na + from 137 mM to 237 mM (P = 0.66, n = 4-16 plates per condition) (Fig. 5I) .
DISCUSSION
Mammalian KCNQ-SMIT complexes belong to a novel class of signaling hubs, other examples of which have been recognized only very recently, but which include a diverse selection of channel-transporter interactions, several of which are linked to pathophysiology when disrupted. The Orai1 Ca 2+ channel, better known for interacting with stromal interaction molecule 1 (21) , can also form complexes with secretory pathway Ca 2+ -ATPase isoform 2 (SPCA2), a P-type calcium ion transporter found in the Golgi (22) . The epithelial sodium channel, ENaC, was recently discovered to interact with the sodium chloride cotransporter NCC in vitro and in the distal convoluted tubule of the kidney (23) . CFTR chloride channels, which also display some properties of ATP-binding cassette transporters, can coassemble with chloride/bicarbonate exchangers from the SLC26A solute transporter family (24, 25) . MaxiK, a Ca 2+ -activated K + channel, was also recently found to coassemble with GAT3, a sodium-dependent g-aminobutyric acid transporter encoded by SLC6A11, in mouse brain and in HEK cells (26) . In addition, KCNQ-SLC5A11 complex formation has also been reported in Drosophila, where up-regulation or overexpression of the Drosophila sodium/solute cotransporter-like SLC5A11 (aka cupcake) causes marked reductions in Drosophila (d) KCNQ expression and macroscopic current. dKCNQ, an ortholog of mammalian KCNQ family a subunits, possesses some characteristics reminiscent of KCNQ1 and some of KCNQ2 (27) . Similar to our prior findings for mammalian SLC5A11 (SMIT2) and KCNQ1 (8) , cupcake inhibits dKCNQ activity, even though it has yet to be demonstrated that cupcake acts as a sugar or cyclic polyol transporter [it does pass sodiumdependent constitutive current, but does not pass glucosedependent current (27) ].
Mammalian neuronal KCNQ2/3 channels are especially enriched in the axon initial segment, where they act as a gatekeeper to limit or facilitate axonal action potential propagation and thus neuronal signaling, and in nodes of Ranvier. We present evidence here that SMIT1 and SMIT2 are also expressed with KCNQ2/3 in these highly architecturally specialized compartments. In the context of such subcompartments, the relevance of our functional findings becomes immediately apparent. In the confines of the axon, it would be expected that PIP 2 diffusion rate would be especially limiting to its movement and therefore could delay SMIT1 or SMIT2 signaling to KCNQ2 or KCNQ3 if the channels and transporters were not colocalized/coassembled. Similarly, in the confines of the axon, their coassembly might also be important for minimizing delays in either partner experiencing changes induced by the other in the electrochemical gradient, although this will require further experimentation to test directly.
We hypothesize that complex formation with KCNQ2/3 might enable the myo-inositol transporter to maintain its function during rapid or frequent cellular depolarizations. This effect could prove cumulative over an extended train of depolarizations, maintaining or potentiating myo-inositol influx and thereby PIP 2 levels to the extent that it could provide a "handbrake" to keep the repolarizing currents of the PIP 2 -sensitive M channel open, which could quell excessive neuronal excitation (28) . Our finding that KCNQ2 inhibits whole-cell myo-inositol uptake by SMIT1 because of a reduction in surface expression of SMIT1 might appear counter to the arguments above. However, we propose that the diminishment of SMIT1 forward trafficking by KCNQ2 in Xenopus oocytes and CHO cells is a surrogate for the precise, highly localized targeting of KCNQ2/3-SMIT1/2 complexes to subcompartments lacking in these cell types-namely the axon initial segment and nodes of Ranvier.
One of the striking commonalities of mice with either Kcnq2 or Slc5a3 (SMIT1) germ line-deleted is that mice of either strain die a few hours after birth from hypoventilation (29, 30) . This hints at the possibility that KCNQ2/3-SMIT1 complexes are important in the respiratory center or in other neuronal populations controlling essential aspects of ventilation, the development of ventilator function, or its regulation. Interestingly, Slc5a3 deletion impairs the development of phrenic nerves, which are important for innervation of the diaphragm to control breathing (31) . In addition, SMIT1 was previously found to be especially important for myo-inositol accumulation in the sciatic nerve, with Slc5a3 disruption reducing both nerve conduction velocity and protein kinase C activity (31) . This is striking, given the established importance of KCNQ2 channels in regulating the nodal slow K v current (I Ks ) within myelinated nerve fibers of the sciatic nerve (13) , and our findings herein that KCNQ2 and KCNQ3 each colocalize with SMIT1 and/ or SMIT2 in sciatic nerves.
We previously found that SMIT1 coassembles with KCNQ1-KCNE2 channels and that these complexes are important for regulating myo-inositol transport between the blood and the cerebrospinal fluid (8) . We found evidence of coregulation by each of the partners in those complexes in the absence of myo-inositol preincubation, including augmentation of activity, sensitivity of SMIT1 to KCNQ1-KCNE2 antagonists, and inhibition of SMIT1 by a mutation that locked open the voltage sensor, or by KCNE2 coassembly with KCNQ1. In the present study, we also uncovered evidence that SMIT1 is sensitive to manipulation of KCNQ2/3 function by chemical inhibition, but we also found that inhibition or transporter function was mediated primarily by reduced surface expression, further supporting the idea that there is direct, consequential contact between these unlikely partners. It is, however, important to add the caveat that there may be an intermediary protein required to facilitate KCNQ-SMIT interaction, a possibility that our coimmunoprecipitation and colocalization studies do not rule out (although the intermediary would need to be endogenously expressed in CHO cells, nodes of Ranvier, and axon initial segments). It will be of interest to return to SMIT1-KCNQ1 complexes in light of the nowestablished influence of PIP 2 in SMIT-KCNQ2/3 cross talk (11) to examine effects of preincubation with myoinositol, given the high sensitivity of KCNQ1 (depending on the KCNE partner) to PIP 2 (32) .
